NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.

Don't have an account? Subscribe

Oropharyngeal cancer, latest approaches (RCPI Ref 1115)

Sponsored by MSD Ireland

Sponsored content is premium paid-for content from commercial clients. The Medical Independent are not involved in the production of this sponsored content.

Woman with thyroid gland problem

2 External Credits – Disclaimer: This independent medical education article was commissioned by MSD Ireland.

Dr Aisling Glynn, Senior SpR in Radiation Oncology, St Luke’s Radiation Oncology Network (SLRON), and Prof Sinead Brennan, Director of Research, SLRON

Reviewed By
Priscilla Lynch

Head and neck cancer (HNC) is a heterogeneous group of malignancies comprised of cancers of the oral cavity, oropharynx, nasopharynx, hypopharynx, larynx, salivary glands, nasal cavity, and paranasal sinuses.


Leave a Reply

Latest Issue
The Medical Independent 26th September 2023

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read